Page last updated: 2024-08-16

risperidone and 4-iodo-2,5-dimethoxyphenylisopropylamine

risperidone has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (28.57)18.2507
2000's6 (42.86)29.6817
2010's3 (21.43)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Glennon, RA1
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R1
Brocco, M; Millan, MJ; Schreiber, R1
Fischer, TR; Hitchcock, JM; Lister, S; Wettstein, JG1
Grottick, AJ; Herberg, LJ; Montgomery, AM1
Bergqvist, PB; Blier, P; Dong, J1
Cuadra, GR; Nasif, FJ; Ramirez, OA1
Bonaccorso, S; Fowler, WL; Ichikawa, J; Ishii, H; Meltzer, HY; O'Laughlin, IA1
Guo, CM; Liang, JH; Shu, L; Si, TM; Su, YA; Wang, XD; Yang, Y; Zhou, DF1
Anderson, GT; Barido, R; Bonhaus, DW; Brann, MR; Brunmark, P; Davis, RE; Dyssegaard, A; Gardell, LR; Hacksell, U; Johnson, RW; Pounds, L; Tabatabaei, A; Vanover, KE; Veinbergs, I1
Rogóż, Z1
Guo, Y; Hu, L; Liu, C; Luo, B; Wang, H1
Alemany-González, M; Chanovas, J; Delgado-Sallent, C; Gener, T; Nebot, P; Puig, MV; Tauste Campo, A1
Basu, B; John Jayakumar, JAK; Panicker, MM1

Reviews

1 review(s) available for risperidone and 4-iodo-2,5-dimethoxyphenylisopropylamine

ArticleYear
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
    Journal of medicinal chemistry, 2003, Jul-03, Volume: 46, Issue:14

    Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists

2003

Other Studies

13 other study(ies) available for risperidone and 4-iodo-2,5-dimethoxyphenylisopropylamine

ArticleYear
Physical binding pocket induction for affinity prediction.
    Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19

    Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A

2009
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
    European journal of pharmacology, 1994, Oct-13, Volume: 264, Issue:1

    Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Fluorobenzenes; Isoxazoles; Male; Motor Activity; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Risperidone; Serotonin Antagonists

1994
Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol.
    Behavioural brain research, 1997, Volume: 88, Issue:1

    Topics: Amphetamines; Animals; Antipsychotic Agents; Clozapine; Conditioning, Operant; Fluorobenzenes; Haloperidol; Male; Piperidines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Reinforcement, Psychology; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists

1997
Rapid recovery of self-stimulation from depression produced by the atypical neuroleptic risperidone is not prevented by 5-HT2 receptor stimulation.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 58, Issue:4

    Topics: Amphetamines; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Risperidone; Self Stimulation; Serotonin Receptor Agonists

1997
Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.
    Psychopharmacology, 1999, Volume: 143, Issue:1

    Topics: Amphetamines; Animals; Antipsychotic Agents; Bicuculline; Clozapine; Electrophysiology; GABA Antagonists; Iontophoresis; Male; Neurons; Piperazines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, GABA-A; Receptors, Serotonin; Risperidone; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists

1999
Effects of chronic risperidone on central noradrenergic transmission.
    European journal of pharmacology, 2000, Apr-07, Volume: 394, Issue:1

    Topics: Amphetamines; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Locus Coeruleus; Male; Microdialysis; Norepinephrine; Rats; Rats, Wistar; Risperidone; Synaptic Transmission

2000
5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Journal of neurochemistry, 2001, Volume: 76, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Dopamine D2 Receptor Antagonists; Male; Microdialysis; Olanzapine; Piperazines; Pirenzepine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sulpiride

2001
Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
    European journal of pharmacology, 2007, Jun-14, Volume: 564, Issue:1-3

    Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Risperidone; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists

2007
ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2

    Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Brain Chemistry; Catalepsy; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Haloperidol; Head Movements; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperidines; Prolactin; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Urea

2007
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
    Pharmacological reports : PR, 2012, Volume: 64, Issue:6

    Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperkinesis; Male; Mianserin; Mice; Mirtazapine; Motor Activity; Risperidone; Schizophrenia; Schizophrenic Psychology

2012
Activation of 5-HT2A/C receptor reduces glycine receptor-mediated currents in cultured auditory cortical neurons.
    Amino acids, 2016, Volume: 48, Issue:2

    Topics: Amphetamines; Animals; Auditory Cortex; Cells, Cultured; GTP-Binding Proteins; Guanosine Diphosphate; Ion Channels; Microtubules; Neurons; Nocodazole; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Glycine; Risperidone; Ritanserin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Strychnine; Thionucleotides; Tubulin Modulators

2016
Serotonin 5-HT
    Neuropharmacology, 2019, 11-01, Volume: 158

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antipsychotic Agents; Brain Waves; Cortical Synchronization; Dopamine Agonists; Dopamine Antagonists; Electroencephalography; Fluorobenzenes; Gamma Rhythm; Haloperidol; Hippocampus; Locomotion; Mice; Neural Pathways; Piperazines; Piperidines; Prefrontal Cortex; Pyridines; Quinpirole; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists

2019
Serotonin 2A (5-HT
    Scientific reports, 2020, 12-10, Volume: 10, Issue:1

    Topics: Amphetamines; Animals; Antipsychotic Agents; Cell-Matrix Junctions; Chlorpromazine; HEK293 Cells; Humans; Mental Disorders; Olanzapine; Rats; Receptor, Serotonin, 5-HT2A; Risperidone; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Stress Fibers

2020